New Study Uncovers How Chills Develop and Bolster the Body’s Defense Against Infection

Why It Matters

Understanding the neural basis of chills reveals how the body coordinates immune defense with behavioral strategies, potentially improving fever management. Targeting the EP3‑LPB‑amygdala axis could treat maladaptive fever or inflammatory disorders.

Key Takeaways

• PGE₂ activates EP3 receptors in LPB to drive warmth‑seeking
• EP3‑expressing LPB neurons project mainly to central amygdala
• Behavioral fever occurs without autonomic shivering in rats
• Study separates neural circuits for autonomic and behavioral fever
• Findings could guide therapies for dysregulated thermoregulation

Pulse Analysis

Fever has long been recognized as a protective response that raises core temperature to hinder pathogen replication, yet the accompanying sensation of chills has remained a clinical mystery. The new study clarifies that chills are not merely a side effect but an orchestrated behavioral response driven by specific neural pathways. By linking peripheral immune signals—particularly prostaglandin E₂—to central brain circuits, the research illustrates how the immune system co‑opts the nervous system to promote actions that support thermoregulatory goals. This integration of immunology and neurobiology reshapes our understanding of sickness behavior.

The investigators pinpointed the lateral parabrachial nucleus (LPB) as the critical hub where prostaglandin E₂ engages EP3 receptors to generate the subjective feeling of cold. Activation of EP3‑expressing LPB neurons redirects signals to the central amygdala, a region traditionally associated with emotional processing, thereby converting a physiological cue into a motivational drive for warmth‑seeking. Importantly, this pathway operates independently of the preoptic area’s autonomic mechanisms, such as shivering and brown‑fat thermogenesis. The delineation of a discrete EP3‑LPB‑amygdala circuit offers a precise target for drugs aimed at modulating behavioral fever without disrupting essential autonomic functions.

Translating these findings to humans could revolutionize the management of febrile illnesses and chronic inflammatory conditions where fever becomes harmful. If a comparable EP3‑mediated circuit exists in people, pharmacological modulation might alleviate excessive chills or prevent maladaptive heat‑seeking behaviors that exacerbate metabolic stress. Moreover, the study’s methodology—combining receptor‑specific agonists, neural tracing, and behavioral assays—sets a template for exploring other neuroimmune interactions, such as pain or fatigue during infection. Future work will need to map the human homologues and assess therapeutic safety, but the potential to fine‑tune the brain‑body fever response is now within reach.